COPPSERS
TBPH icon

Commonwealth of Pennsylvania Public School Employees Retirement System’s Theravance Biopharma TBPH Stock Holding History

Commonwealth of Pennsylvania Public School Employees Retirement System’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,437
Closed -$167K – 1811
2022
Q3 		$167K Buy
+16,437
New +$154K ﹤0.01% 1799

Other funds holding TBPH

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System's TBPH Position: Q4 2022 in Review

Commonwealth of Pennsylvania Public School Employees Retirement System sold out of Theravance Biopharma (TBPH) in Q4 2022, closing a stake of 16,437 shares — an estimated $167K sold.

Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in TBPH in Q3 2022 and held it in 1 quarter. The position peaked at $167K in Q3 2022. 119 funds tracked by Wall St. Rank hold TBPH as of Q4 2022.

  • Commonwealth of Pennsylvania Public School Employees Retirement System reported no remaining Theravance Biopharma position as of Q4 2022 after selling out during the quarter.
  • Commonwealth of Pennsylvania Public School Employees Retirement System sold 16,437 Theravance Biopharma shares in Q4 2022, an estimated $167K.
  • Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in Theravance Biopharma in Q3 2022 and held it in 1 quarter.
  • Commonwealth of Pennsylvania Public School Employees Retirement System's Theravance Biopharma position peaked at $167K in Q3 2022.
  • 119 funds tracked by Wall St. Rank held Theravance Biopharma as of Q4 2022.

Based on Commonwealth of Pennsylvania Public School Employees Retirement System's 13F filing for Q4 2022, filed 13 Feb 2023.